2025 first_quarter Filing
Q1Income
$60K
Filed
April 21, 2025
Lobbying Activities
DefenseView all
National security issues related to pharmaceutical industry, including supply chain.
Trade (domestic/foreign)View all
Trade policies and agreements, including IP protections, and administrative tariff actions.
PharmacyView all
Policies and proposals impacting pharmaceutical development, approval, manufacturing, and reimbursement, including rebates and prices.
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Health IssuesView all
S. 832, EPIC Act of 2025.
Lobbyists (5)
RICHARD BURR
KARINA LYNCH
MARGARET MARTIN
RACHEL PORTMAN